Calendar Eli Lilly and Company

Equities

LLY

US5324571083

Market Closed - Nyse 04:00:02 2024-05-17 pm EDT 5-day change 1st Jan Change
770 USD -0.15% Intraday chart for Eli Lilly and Company +1.32% +32.09%

Chart calendar Eli Lilly and Company

136d41e993da8dae822987d3e.eOp1qPp9RQLnkAOU-U60uWWhJgImAMF5lCyte68rhfs.NZMP-pVQM26swXShniHmjg3mcGFocqUSw3bvDsN-068oqxf9mzIDQInUNw~42cd8c60da6b547da5baca7e121befc4

Upcoming events on Eli Lilly and Company

2024-06-21 03:45 pm American Diabetes Association Scientific Symposium
2024-08-08 06:25 am Q2 2024 Earnings Release
2024-08-08 10:00 am Q2 2024 Earnings Call
2024-10-30 06:25 am Q3 2024 Earnings Release
2024-10-30 10:00 am Q3 2024 Earnings Call
2025-01-29 Q4 2024 Earnings Release (Projected)
2025-04-23 Q1 2025 Earnings Release (Projected)
2025-08-04 Q2 2025 Earnings Release (Projected)
2025-11-03 Q3 2025 Earnings Release (Projected)

Past events on Eli Lilly and Company

2024-05-14 Ex-dividend day
2024-05-06 08:30 am Annual General Meeting
2024-04-30 10:00 am Q1 2024 Earnings Call
2024-04-30 06:45 am Q1 2024 Earnings Release
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Abstract Number: 3230
2024-04-08 04:30 pm American Association for Cancer Research Meeting - Abstract Number: 3316
2024-04-08 12:00 pm American Association for Cancer Research Meeting - Abstract Number: 1872
2024-03-09 American Academy of Dermatology Meeting
2024-03-06 09:10 am TD Cowen Health Care Conference - Fireside Chat
2024-02-13 Ex-dividend day
2024-02-06 10:00 am Q4 2023 Earnings Call
2024-02-06 06:45 am Q4 2023 Earnings Release
2024-01-09 05:15 pm JPMorgan Healthcare Conference
2023-12-11 09:00 pm American Society of Hematology Meeting - Abstract No:5152
2023-12-11 08:00 pm American Society of Hematology Meeting - Abstract No:981
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3269
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3626
2023-12-10 09:00 pm American Society of Hematology Meeting - Abstract No:3026
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract No:1660
2023-12-09 08:30 pm American Society of Hematology Meeting - Abstract No:1737

Past dividends on Eli Lilly and Company

2024-05-14 Quarterly 1.3 USD
2024-02-13 Quarterly 1.3 USD
2023-11-13 Quarterly 1.13 USD
2023-08-13 Quarterly 1.13 USD
2023-05-11 Quarterly 1.13 USD
2023-02-13 Quarterly 1.13 USD
2022-11-13 Quarterly 0.98 USD
2022-08-11 Quarterly 0.98 USD
2022-05-12 Quarterly 0.98 USD
2022-02-13 Quarterly 0.98 USD

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million USD
Released
Forecast
Spread
22 320
22 142
0.8%
24 540
24 394
0.6%
28 318
28 205
0.4%
28 541
28 641
-0.35%
34 124
33 585
1.6%

42 999

EBITDA
Million USD
Released
Forecast
Spread
7 551
7 508
0.57%
8 589
8 676
-1.01%
10 005
9 767
2.43%
9 473
9 494
-0.23%
8 584
8 418
1.98%

16 205

EBIT
Million USD
Released
Forecast
Spread
6 079
6 106
-0.44%
7 265
7 503
-3.17%
8 457
8 599
-1.65%
7 950
8 164
-2.62%
7 057
6 928
1.86%

14 694

Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread
5 266
8 975
-41.33%
7 230
7 041
2.68%
6 156
7 148
-13.88%
6 806
7 084
-3.93%
6 555
6 311
3.86%

13 737

Net income
Million USD
Released
Forecast
Spread
8 318
8 090
2.83%
6 194
5 805
6.69%
5 582
6 019
-7.27%
6 245
6 102
2.35%
5 240
5 307
-1.26%

11 932

EPS
USD
Released
Forecast
Spread
8,89
8,65
2.83%
6,79
6,36
6.69%
6,12
6,43
-4.75%
6,90
6,60
4.57%
5,80
6,04
-3.92%

13,4

Announcement Date30/01/2029/01/2103/02/2202/02/2306/02/24-

Quarterly results

Fiscal PeriodDecember 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales
Million USD
Released
Forecast
Spread
7 810
7 319
6.7%
6 488
6 854
-5.33%
6 942
6 901
0.58%
7 302
7 376
-1%
6 960
6 867
1.36%
8 312
7 590
9.51%
9 499
8 965
5.96%
9 353
8 971
4.27%
8 768
8 930
-1.81%

10 008


11 328


12 796


10 920


12 135

EBITDA
Million USD
Released
Forecast
Spread
3 046
2 717
12.12%
1 679
2 387
-29.67%
2 373
2 385
-0.5%
2 375
2 268
4.72%
1 982
2 148
-7.73%
2 618
2 416
8.39%
986
3 460
-71.49%
2 855
3 517
-18.81%
3 049
2 827
7.84%

3 747


4 838


5 994







EBIT
Million USD
Released
Forecast
Spread
2 610
2 336
11.74%
1 330
1 790
-25.7%
2 010
2 007
0.13%
2 000
1 953
2.41%
1 620
1 840
-11.95%
2 252
2 078
8.37%
575
921
-37.56%
2 468
2 448
0.79%
2 648
2 674
-0.96%

3 080


3 976


4 816







Earnings before Tax (EBT)
Million USD
Released
Forecast
Spread















2 089
2 107
-0.86%
427
-399
207.07%
2 509
1 248
101.03%
2 536
2 455
3.3%

3 000


3 878


4 497







Net income
Million USD
Released
Forecast
Spread
1 903
1 711
11.22%
953
1 133
-15.93%
1 452
1 453
-0.09%
1 938
1 681
15.27%
1 345
1 544
-12.9%
1 763
1 660
6.22%
-57,4
-813
92.94%
2 190
1 811
20.89%
2 243
2 058
8.99%

2 477


3 249


4 025







EPS
USD
Released
Forecast
Spread



1,05
1,85
-43.24%
1,61
1,90
-15.26%
2,14
1,78
20.22%
1,49
2,04
-26.96%
1,95
1,81
7.73%
-0,06
-0,66
90.91%
2,42
2,26
7%
2,48
2,44
1.64%

2,77


3,60


4,46







Announcement Date28/04/2204/08/2201/11/2202/02/2327/04/2308/08/2302/11/2306/02/2430/04/24-----

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. LLY Stock
  4. Calendar Eli Lilly and Company
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW